CME/CE
81-96 of 123
- CME/CE Broadcast Replay
Risk Assessment in Pulmonary Hypertension: Practice Trends and Updates
1.00 credit
Robert P. Frantz, MD, FACC
Vallerie V. McLaughlin, MD
Sonja Bartolomei, MD
Vallerie V. McLaughlin, MD
Victor Moles, MD
Ioana Preston, MD
Vallerie V. McLaughlin, MD
Thomas Cascino, MD
Bradley A. Maron, MD
- CME/CE
The Shifting ATTR-CM Landscape: Early Diagnosis, Emerging Therapies & Personalized Care
0.50 creditsPablo Garcia-Pavia, MD, PhD
Francesco Cappelli, MD
Csaba P. Kovesdy, MD
Finnian R. McCausland, MD
Csaba P. Kovesdy, MD
Finnian R. McCausland, MD
Ira J. Goldberg, MD
Kausik Ray, MBChB, MD, MPhil
Christie Ballantyne, MD
Akshay S. Desai, MD
John McMurray, MD
Akshay S. Desai, MD
John McMurray, MD
- MinuteCE®
Clinical choices in managing LDL-c: Where do novel therapies fit in?
0.75 credits 4 episodesKausik Ray, MBChB, MD, MPhil
Julia Brandts, MD
Pasquale Perrone-Filardi, MD, PhD
Ulrich Laufs, MD, PhD
Gianluigi Savarese, MD
James Burton, DM, FRCP
Aaron Wong, MD
Gianluigi Savarese, MD
James Burton, DM, FRCP
Aaron Wong, MD
Gianluigi Savarese, MD
- MinuteCE®
The remaining challenges in lowering LDL-c in patients at increased CV risk
0.75 program creditsProf. Kausik Ray
- MinuteCE®
Reaching LDL-c targets in patients at high CV risk: How well are we doing?
0.75 program creditsJulia Brandts, MD
